Sponsored by:

Tumor > Neotect

Scott Williams
Apr 2, 2002

Neotect (Tc99-m-Depreotide) (P-829)

Clinical

Chemistry and pharmacology

Patient Instructions

Imaging Protocol

Interpretation

Indications for the exam

Dosimetry

Complications/Side Effects

HAMA Formation (Immunogenicity)



Latest in Nuclear Medicine
Herrman Ken Thumbnail
Journal of Nuclear Medicine names new editor in chief
February 11, 2026
New! Biograph Trinion.X PET/CT
Sponsored
New! Biograph Trinion.X PET/CT
February 1, 2026
Ai Abstract Researcher (1)
Nucs AI establishes medical advisory board
January 29, 2026
Prostate
New study seeks to tailor RLT to individual patients
January 26, 2026
Related Stories
Whole Body
Nuclear Medicine
Prostascint (111In-Capromab Pendetide) (CYT-356)
Primary Ct
Nuclear Medicine
PET > PET tumor imaging > Breast Cancer
Lsegs
Nuclear Medicine
Pulmonary
New! Biograph Trinion.X PET/CT
Sponsor Content
New! Biograph Trinion.X PET/CT
More in Nuclear Medicine
Journal of Nuclear Medicine names new editor in chief
By AuntMinnie.com staff writers
Herrmann is currently chair of nuclear medicine at the University of Duisburg-Essen in Germany.
February 11, 2026
Herrman Ken Thumbnail
Niowave inks Ac-225 supply deal with Novartis
By AuntMinnie.com staff writers
The agreement will provide Novartis with a supply of the medical isotope to support its growing portfolio of radioligand therapies.
February 11, 2026
Isotopes1
Nucs AI establishes medical advisory board
By AuntMinnie.com staff writers
Nucs AI has formed its medical advisory board to ensure the company's AI theranostics tech is aligned with clinical practice.
January 29, 2026
Ai Abstract Researcher (1)
New study seeks to tailor RLT to individual patients
By Will Morton
A new clinical trial aims to determine how doctors can optimize targeted radioligand therapy (RLT) for men with prostate cancer.
January 26, 2026
Prostate
Georgia ProtonCare Center enters asset purchase agreement with Emory
By AuntMinnie.com staff writers
Georgia ProtonCare Center has entered into an asset purchase agreement with Emory University.
January 22, 2026
Business Development Graph Up 400
New theranostic pairing shows promise for upper gastrointestinal tumors
By AuntMinnie.com staff writers
A new theranostic pairing shows promise for detecting and effectively treating gastric and pancreatic tumors.
January 13, 2026
Atom Nuclear Lab 400
Theranostic pair ready for testing in lung cancer
By Will Morton
Gallium-68 (Ga-68) SSO120 PET/CT successfully visualized lesions in patients during and after chemotherapy.
January 8, 2026
2025 01 08 Ssr2 Thumbnail
Archeus Technologies names new slate of executives
By AuntMinnie.com staff writers
The new team will lead the company as it enters its next stage of clinical growth.
January 7, 2026
Handshake
Niowave expands supply agreement with AstraZeneca
By AuntMinnie.com staff writers
Niowave is expanding its supply agreement with AstraZeneca to a 10-year commitment to deliver actinium-225.
December 18, 2025
Manufacturing Facility Process 400
AtomVie signs supply agreement with Ionetix for Ac-225 development
By AuntMinnie.com staff writers
AtomVie has entered a strategic partnership with Ionetix for the development of actinium-225 (Ac-225) for AtomVie's partners worldwide.
December 18, 2025
Business Handshake 400
RadioMedix secures Th-228 supply
By AuntMinnie.com staff writers
The supply will support the company's advancing cancer therapeutics pipeline.
December 17, 2025
Isotopes1
UCLA to launch department of nuclear medicine and theranostics
By AuntMinnie.com staff writers
The University of California, Los Angeles (UCLA) will open a department of nuclear medicine and theranostics on January 1, 2026.
November 19, 2025
Nuclearmedicine
Page 1 of 440
Next Page